Smart Olfaction App for Smoking Addiction

(SOARR Trial)

LG
Overseen ByLorra Garey, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: University of Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to help people quit smoking by combining a smartphone app with a scent-based system to reduce cigarette cravings. Participants will use either the Smart Olfaction App alone or the app with the scent system to determine which is more effective. It suits individuals who smoke at least five cigarettes a day, are motivated to quit, and own an Apple or Android smartphone. As an Early Phase 1 trial, this research aims to understand how the treatment works in people, offering participants the opportunity to be among the first to try this innovative approach.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this olfactory stimulation delivery system is safe for smoking cessation?

Research has shown that smoking cessation apps, like the Smart-T app, can help people quit smoking. In studies, users of Smart-T were almost twice as likely to quit compared to those using another app called QuitGuide. This suggests that Smart-T effectively aids users in stopping smoking.

Regarding safety, this trial is in its earliest phase, meaning the app is just beginning safety testing in people. Although specific safety data for the Smart Olfaction App is not yet available, smoking cessation apps generally are safe to use. They do not involve medication, so they tend to have fewer side effects.

In summary, while specific safety data for the Smart Olfaction App is not yet available, similar apps have been safe for users and effective in helping people quit smoking.12345

Why are researchers excited about this trial?

Researchers are excited about the Smart Olfaction App for smoking addiction because it offers a novel approach to tackling nicotine dependence. Unlike traditional methods such as nicotine replacement therapy (NRT) or medications like varenicline, this app uses smell to influence cravings and smoking behavior. The app's unique mechanism involves olfactory stimulation, which could potentially alter smoking habits by using specific scents to reduce the urge to smoke. Another exciting aspect is its integration with the Inspire device, further enhancing its effectiveness by combining digital health with sensory cues. This innovative approach could pave the way for more personalized and effective smoking cessation strategies.

What evidence suggests that this trial's treatments could be effective for smoking addiction?

Research has shown that smartphone apps can help people quit smoking. One study found that the Smart-T app, which participants in this trial may use, worked better for adults with lower income levels compared to another popular app. A review of several studies demonstrated that mobile apps can help more smokers quit. Although the Stop-tabac app did not increase quitting rates, it encouraged more people to use nicotine medications. These findings suggest that using a smartphone app like Smart-T, along with scent-based methods, could reduce cigarette cravings and support efforts to quit smoking. Participants in this trial may also use the Inspire device in different phases to further aid smoking cessation.14678

Who Is on the Research Team?

LG

Lorra Garey, Ph.D.

Principal Investigator

University of Houston

MB

Michael Businelle, Ph.D.

Principal Investigator

University of Oklahoma Health Sciences

MS

Michael Sayette, Ph.D.

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for individuals trying to quit smoking and are comfortable using smartphone apps. Participants should be willing to use the Smart-T Smoking Cessation App and may also be asked to use a device called Inspire that delivers olfactory stimulation. People who don't want to engage with technology or have conditions that interfere with app/device usage cannot join.

Inclusion Criteria

Currently smoke at least 5 cigarettes daily for one year or longer
Willing and able to complete study procedures
Motivated to quit smoking
See 7 more

Exclusion Criteria

Being pregnant by self-report
Have a smartphone that is not compatible with the Insight mHealth platform
Not being fluent in English
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
Initial online pre-screener and enrollment call

Phase I: Treatment

Participants engage in a self-guided quit attempt using the OSDS for 14 days with crossover randomization design

2 weeks
5 daily EMAs, baseline survey, randomization call, qualitative interview over Zoom

Phase II: Treatment

Participants are randomized to Smart-T with or without OSDS and use a nicotine patch for smoking cessation

13 weeks
Daily EMAs, baseline assessment, follow-up assessment at 12 weeks post-quit

Follow-up

Participants are monitored for smoking abstinence and device acceptability

12 weeks
Follow-up assessment via app, qualitative interview over Zoom

What Are the Treatments Tested in This Trial?

Interventions

  • Smart Olfaction App
Trial Overview The study tests if combining an app (Smart-T) designed for quitting smoking with a scent-delivering device (Inspire) helps people stop smoking better than just the app alone. Some will use nicotine replacement therapy as well. It's a pilot randomized controlled trial, meaning participants are randomly assigned to different groups.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Phase II: Smart-T app + NRT + InspireExperimental Treatment3 Interventions
Group II: Phase I: Instructed Use followed by Ad Libitum Use of the Inspire DeviceExperimental Treatment3 Interventions
Group III: Phase I: Ad Libitum followed by Instructed Use of the Inspire DeviceExperimental Treatment3 Interventions
Group IV: Phase II: Smart-T + NRTActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Houston

Lead Sponsor

Trials
155
Recruited
48,600+

University of Pittsburgh

Collaborator

Trials
1,820
Recruited
16,360,000+

University of Oklahoma

Collaborator

Trials
484
Recruited
95,900+

Brown University

Collaborator

Trials
480
Recruited
724,000+

Citations

The Stop‐tabac smartphone application for smoking ...The Stop‐tabac smoking cessation app did not increase smoking cessation rates, but increased rates of use of nicotine medications.
Effectiveness of Mobile Apps for Smoking CessationThe review of eight selected studies illustrate the use of smartphone applications in increasing quit rates among smokers.
Quit Rate Higher With Smart-T vs NCI QuitGuideThe Smart-T app may more effectively support smoking cessation in adults with lower socioeconomic status than the NCI QuitGuide app.
Exploring relationships among smoking cessation app use, ...Exploring relationships among smoking cessation app use, smoking behavioral outcomes, and pharmacotherapy utilization among individuals who smoke cigarettes.
Smart Olfaction App for Smoking Addiction (SOARR Trial)This trial is for individuals trying to quit smoking and are comfortable using smartphone apps. Participants should be willing to use the Smart-T Smoking ...
The Stop-Tabac smartphone application for smoking ...The objectives of this study are to assess whether the Stop-Tabac application (app) is effective for smoking cessation and to examine whether the outcome is ...
University of Oklahoma's Smoking Cessation App Performs ...After six months of using the apps, those who used Smart-T were nearly twice as likely to have quit smoking than those who used the QuitGuide ...
Smartphone App-Based Interventions to Support Smoking ...Smartphone apps have emerged as cost-effective tools to aid smokers in quitting; however, their evidence-based foundation remains understudied.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security